Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

SLN Silence Therapeutics PLC

18,95

0,05 (0,26%)

21 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

Silence Therapeutics (NASDAQ:SLN)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Silence Therapeutics Charts.

Silence Therapeutics (NASDAQ:SLN)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Silence Therapeutics Charts.

News Silence Therapeutics PLC

Silence Therapeutics Announces Positive Topline 48-Week Data from Phase 2 Study of Zerlasiran in Patients with Elevated Lipoprotein(a)
Donnerstag 20 Juni 2024 (18 Stunden vor) • Business Wire

Silence Therapeutics to Present at Jefferies Global Healthcare Conference
Donnerstag 30 Mai 2024 (3 Wochen vor) • Business Wire

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Freitag 17 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Donnerstag 16 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Silence Therapeutics Reports First Quarter 2024 Results and Highlights Pipeline Progress
Donnerstag 16 Mai 2024 (1 Monat vor) • Business Wire

Form 424B3 - Prospectus [Rule 424(b)(3)]
Dienstag 14 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Form DEL AM - Delaying amendment
Mittwoch 8 Mai 2024 (1 Monat vor) • Edgar (US Regulatory)

Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright 2nd Annual BioConnect Investor Conference
Dienstag 30 April 2024 (2 Monate vor) • Business Wire

Silence Therapeutics Announces Retirement of Alistair Gray from Board of Directors
Montag 29 April 2024 (2 Monate vor) • Business Wire

Silence Therapeutics Announces JAMA Publication of Additional Phase 1 Data for Zerlasiran in Subjects with Elevated Lipoprotein(a)
Montag 8 April 2024 (2 Monate vor) • Business Wire

Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights
Mittwoch 13 März 2024 (3 Monate vor) • Business Wire

Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb
Mittwoch 13 März 2024 (3 Monate vor) • IH Market News

Weitere Silence Therapeutics PLC News-Artikel

Australian Critical Mine...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen